Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review

Sajad Fakhri1, Seyed Zachariah Moradi2, Angela Ash-Rafzadeh3

  • 1Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, Iran.

Pharmacological Research
|October 31, 2021
PubMed

Insights

Natural compounds can fight cancer by controlling cellular senescence pathways. These agents promote cancer cell senescence while reducing harmful signals in neighboring cells, offering chemopreventive and chemotherapeutic potential.

Area of Science:

  • Oncology
  • Cell Biology
  • Natural Product Chemistry

Background:

  • Cellular senescence has a dual role in cancer, suppressing tumors but also promoting tumorigenesis via senescence-associated secretory phenotypes (SASPs).
  • Targeting both cancer cell senescence induction and SASP suppression is crucial for effective cancer therapy.
  • Natural secondary metabolites, including phenolic compounds, terpenes, and alkaloids, show promise as anticancer agents by modulating senescence pathways.

Purpose of the Study:

  • To systematically review the role of natural secondary metabolites in regulating cellular senescence.
  • To elucidate the chemopreventive and chemotherapeutic potential of these compounds.
  • To identify key molecular targets within autocrine and paracrine senescence pathways.

Main Methods:

  • Systematic review of scientific literature on natural secondary metabolites and cellular senescence.
  • Analysis of phytochemical mechanisms targeting senescence-associated secretory phenotypes (SASPs).
  • Identification of key signaling pathways (e.g., PI3K/Akt/mTOR, JAK/STAT) modulated by phytochemicals.

Main Results:

  • Natural secondary metabolites effectively regulate both autocrine and paracrine senescence pathways.
  • Phytochemicals can induce senescence in cancer cells and suppress pro-tumorigenic SASP factors.
  • These compounds target key mediators involved in cell cycle arrest, apoptosis, inflammation, and oxidative stress.

Conclusions:

  • Natural secondary metabolites possess significant chemopreventive and chemotherapeutic capabilities by modulating cellular senescence.
  • Targeting senescence pathways with natural compounds offers a promising strategy for cancer treatment.
  • Further research is needed to address challenges and fully harness the potential of these agents.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
15.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Telomeres and Telomerase02:41

Telomeres and Telomerase

6.0K